GLIN Performance — VanEck India Growth Leaders ETF
Data updated: 2026-08-26
GLIN returned +0.26% year to date and −3.16% over one year to Jun 2026. Annualised returns are +10.37% over 3 years and +5.01% over 5 years. The fund beat its India Equity category average: $100 invested three years ago grew to $134, against $119 for the category, and to $97 over one year, against $89. Volatility over the past three years was 19.18% a year. In the 12 months to Jun 2026 the fund lost a net $28.2M, and assets reached $98.57M.
GLIN Growth of $100
What $100 invested in VanEck India Growth Leaders ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the India Equity category average over the same months.
| Period | GLIN | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $97 | $89 |
| 3 years (Jul 2023 – Jun 2026) | $134 | $119 |
| 5 years (Jul 2021 – Jun 2026) | $128 | $121 |
| Since data start (Jul 2019 – Jun 2026) | $133 | $156 |
GLIN Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +0.26% |
| 1 year | −3.16% |
| 3 years (annualised) | +10.37% |
| 5 years (annualised) | +5.01% |
GLIN Annual Returns
Calendar-year total returns of VanEck India Growth Leaders ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +0.26% |
| 2025 | −4.92% |
| 2024 | +16.12% |
| 2023 | +35.50% |
| 2022 | −22.00% |
| 2021 | +29.15% |
| 2020 | +0.81% |
| 2019 (Jul–Dec) | −12.89% |
GLIN Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −2.2% | +2.2% | −14.5% | +13.9% | +0.8% | +2.2% | — | — | — | — | — | — |
| 2025 | −8.6% | −11.6% | +8.5% | +3.5% | +5.3% | +3.0% | −7.8% | −1.1% | +1.7% | +3.7% | −0.1% | +0.5% |
| 2024 | +4.0% | +4.1% | −0.9% | +1.9% | −0.4% | +6.0% | +5.2% | +1.2% | +1.1% | −5.1% | +0.1% | −1.7% |
| 2023 | +1.8% | −4.4% | +0.5% | +4.7% | +3.1% | +5.6% | +2.8% | +0.6% | +2.6% | −1.7% | +8.5% | +7.5% |
| 2022 | −5.5% | −5.2% | +5.1% | −4.8% | −10.4% | −7.9% | +8.8% | −0.4% | −5.4% | +2.2% | +5.6% | −4.7% |
| 2021 | −1.8% | +1.3% | +4.3% | +2.9% | +8.5% | +2.3% | +3.7% | +5.6% | −0.9% | −2.0% | −2.7% | +5.5% |
| 2020 | +6.0% | −9.7% | −35.8% | +14.2% | −0.2% | +5.6% | +9.4% | +3.5% | +2.5% | +0.8% | +6.5% | +9.2% |
| 2019 | — | — | — | — | — | — | −12.3% | −5.1% | +2.1% | +3.0% | −0.5% | +0.1% |
GLIN Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 19.18%
- 3-year Sharpe ratio: 0.31 (vs 4.5% risk-free rate)
- Best month: +13.85% (Apr 2026)
- Worst month: −14.51% (Mar 2026)
GLIN Fund Flows
Monthly money in and out of VanEck India Growth Leaders ETF, from SEC Form N-PORT.
- 12-month net flow: −$28.2M
- 12-month gross sales (incl. reinvestments): $85.9M
- Sales ÷ redemptions: 0.75×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $0 | $2.2M | −$2.2M |
| May 2026 | $0 | $2.3M | −$2.3M |
| Apr 2026 | $0 | $18.3M | −$18.3M |
| Mar 2026 | $0 | $66.3M | −$66.3M |
| Feb 2026 | $83.6M | $0 | $83.6M |
| Jan 2026 | $0 | $6.8M | −$6.8M |
| Dec 2025 | $0 | $4.7M | −$4.7M |
| Nov 2025 | $2.3M | $2.3M | $0 |
| Oct 2025 | $0 | $2.3M | −$2.3M |
| Sep 2025 | $0 | $6.8M | −$6.8M |
| Aug 2025 | $0 | $2.2M | −$2.2M |
| Jul 2025 | $0 | $0 | $0 |
GLIN Assets Under Management
Net assets of VanEck India Growth Leaders ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $98.57M |
| 2026-03-31 | $105.78M |
| 2025-12-31 | $119.15M |
| 2025-09-30 | $119.78M |
| 2025-06-30 | $138.87M |
| 2025-03-31 | $132.22M |
| 2024-12-31 | $153.35M |
| 2024-09-30 | $164.50M |
| 2024-06-30 | $147.79M |
| 2024-03-31 | $134.98M |
| 2023-12-31 | $95.19M |
| 2023-09-30 | $66.51M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.